The right time, the right place: will targeting human cancer-associated mutations to the mouse provide the perfect preclinical model?
Karen Blyth, Jennifer P Morton, Owen J SansomVolume:
22
Year:
2012
Language:
english
DOI:
10.1016/j.gde.2012.02.009
File:
PDF, 1.17 MB
english, 2012